研究结果 研究共纳入963例非选定患者（all-comer）（ACURATE=264，Evolut=306，SAPIEN=393）。在基线时，ACURATE组患者年龄相对更大（P<0.001）且女性患者比例更 ...

with a rate of 9.4% for Evolut compared to 10.6% for Sapien. Additionally, Evolut demonstrated superior valve function, with a lower rate of bioprosthetic valve dysfunction at one year ...